Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
The sure signs business is looking up in SA: William Buck Survey of Business Expectations in review

2018-08-20 perthnow.com.au
SOUTH Australian businesses are riding a wave of confidence, and they have every reason to be optimistic about the state’s future.
OZMLF OZL

0
Cassini Resources adds Tinci Materials chairman to registry with $4.2 million raising

2018-08-17 proactiveinvestors.com.au
Cassini Resources Ltd (ASX:CZI) (FRA:ICR) has completed a $4.2 million placement to high-quality investors, adding Guangzhou Tinci Materials Technology Co Ltd chairman Xu Jinfu as a cornerstone investor as it progresses the West Musgrave project feasibility study with partner OZ Minerals Limited (ASX:OZL) (FRA:OXR) (OTCMKTS:OZMLF).
OZMLF OZL CSSQF CZI

0
Cassini Resources adds Tinci Materials chairman to registry with $4.2 million raising

2018-08-17 proactiveinvestors.com.au
Cassini Resources Ltd (ASX:CZI) has completed a $4.2 million placement to high-quality investors, adding Guangzhou Tinci Materials Technology Co Ltd chairman Xu Jinfu as a cornerstone investor as it progresses the West Musgrave project feasibility study with partner OZ Minerals Limited (ASX:OZL).
OZMLF OZL CSSQF CZI

0
OZ Minerals Ltd. 2018 Q2 - Results - Earnings Call Slides

2018-08-16 seekingalpha
The following slide deck was published by OZ Minerals Ltd. in conjunction with their 2018 Q2 earnings call.
OZMLF OZL

0
Mining and energy lead Australian mid-market M&A in 2018

2018-08-16 australianmining.com.au
Australian mergers & acquisitions (M&A) in the first half of 2018 were propelled by the energy, mining and utilities sectors in the mid-market, which represented 26 per cent of mid-market deals in the period.
OZMLF OZL

0
OZ Minerals delivers development progress as profits spike

2018-08-16 australianmining.com.au
OZ Minerals has significantly increased its profits so far this year after benefitting from higher copper prices and improved operational efficiencies.
OZMLF OZL

0
OZ Minerals completes compulsory acquisition of Avanco

2018-08-09 australianmining.com.au
OZ Minerals now owns 100 per cent of Avanco Resources’ shares through subsidiary OZ Minerals Brazil as the $418 million acquisition of Avanco’s outstanding shares has moved to completion.
OZMLF AVB OZL

0
Avrupa Progress on Portugal Projects

2018-08-07 globenewswire
VANCOUVER, B.C., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Avrupa Minerals Ltd. (TSXV:AVU) (OTC:AVPMF) (FRANKFURT:8AM) (“Avrupa” or the Company”) is pleased to provide an update on its recent exploration activities in Portugal.
AVU OZMLF AVPMF BHR OZL

5
Five Things to Watch for in Australia's August Earnings Season - Bloomberg

2018-07-31 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SGM QRNNF MALRY SETY AMP AZJ SMSMY TTRAF 0035 TLSYY MIN SMUPF GS GLSSP CWLDF CCLAY CCL SREN TWE FRTCF TSRYY JBK GSC CWN TFG AZKHY CCLAF AZNNY GSJ TSRYF OZMLF TLS CWLDY OZL MALRF GJS

7
Investors in Australia look set for dividend bonanza

2018-07-30 thestar.com.my
SYDNEY: The world’s third-highest dividend yielding developed market is expected to boost payouts to the most in at least four years as investors reap the benefits of a resources-based economy.
QRNNF RIO BLT RIO AZJ TTRAF TLSYY RTPPF SGAPY RTNTF FMG C BHPBF TPPTY AZKHY TPM AZNNY SNGNF FSUGY OZMLF TPGTF FSUMF BHP RIO CGBBW TLS BBL BHP OZL BHPLF

2
Dividend bonanza: Investors to cash in on commodity boom

2018-07-30 theage.com.au
The world's third-highest dividend yielding developed market is expected to boost payouts to the most in at least four years as investors reap the benefits of a resources-based economy.
QRNNF RIO BLT RIO AZJ TTRAF TLSYY RTPPF SGAPY RTNTF FMG BHPBF TPPTY AZKHY TPM AZNNY SNGNF FSUGY OZMLF TPGTF FSUMF BHP RIO TLS BBL BHP OZL BHPLF

2
Dividend bonanza: Investors to cash in on commodity boom

2018-07-30 smh.com.au
The world's third-highest dividend yielding developed market is expected to boost payouts to the most in at least four years as investors reap the benefits of a resources-based economy.
QRNNF RIO BLT RIO AZJ TTRAF TLSYY RTPPF SGAPY RTNTF FMG BHPBF TPPTY AZKHY TPM AZNNY SNGNF FSUGY OZMLF TPGTF FSUMF BHP RIO TLS BBL BHP OZL BHPLF

2
ASX closes lower as financials fall on disappointing inflation figures

2018-07-25 theage.com.au
A base metal rebound was not enough to help the Australian sharemarket fight off losses after inflation figures came in below expectations.
RIO BLT RIO MDBPF IGO RTPPF RTNTF MS TWE TSRYY BHPBF IIDDY MDBKY TSRYF MPL OZMLF BHP RIO BBL BHP OZL BHPLF

2
ASX closes lower as financials fall on disappointing inflation figures

2018-07-25 smh.com.au
A base metal rebound was not enough to help the Australian sharemarket fight off losses after inflation figures came in below expectations.
RIO BLT RIO MDBPF IGO RTPPF RTNTF MS TWE TSRYY BHPBF IIDDY MDBKY TSRYF MPL OZMLF BHP RIO BBL BHP OZL BHPLF

17
Cobalt Miners News For The Month Of July 2018

2018-07-23 seekingalpha
Cobalt market news - Darton forecasts 40% growth in cobalt demand in 2018. Tony Southgate (ERG) says: "The cobalt boom is guaranteed for the next seven to 10 years."
SIE PIO CLA PANRF RIO CCZ PAN HAV MCR KBGCF CTM FCX AXE IGO VIC BAR AOU HIG PCRCF PLM.RT SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR SHERF CDU RGARF CHK MCRZY CLQ FTMDF KAT RIO RER CSSQF GMRSF CZN PGM GBLEF NZRIF RIO AZS GLCNF DLE HBNRF MEI PIONF CZI AMSLF BPLNF HMI POS AUZ RNX RTPPF GME RTNTF FQVLF AQR PTNUF FT HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF FTSSF KATFF BBBMF MLXEF OZMLF PLM CNJ AZRMF HLPCF BPL BHP OZL ARV

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...